scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1090851360 |
P356 | DOI | 10.1186/S12935-017-0441-7 |
P932 | PMC publication ID | 5521079 |
P698 | PubMed publication ID | 28736504 |
P50 | author | Saleh S. Baeesa | Q38543685 |
Hans-Juergen Schulten | Q57412722 | ||
Deema Hussein | Q88585977 | ||
P2093 | author name string | Ghazi Damanhouri | |
Angel Carracedo | |||
Adeel Chaudhary | |||
Adel Abuzenadah | |||
Awatif Jamal | |||
Fahad Alghamdi | |||
Hanadi Qashqari | |||
Ishaq Khan | |||
Jaudah Al-Maghrabi | |||
Mohamad Saka | |||
Mohammed Bangash | |||
Nawal Madkhali | |||
Saleh Al-Karim | |||
Kulvinder Saini | |||
Mohammed AlQahtani | |||
P2860 | cites work | A-kinase-anchoring protein 95 functions as a potential carrier for the nuclear translocation of active caspase 3 through an enzyme-substrate-like association | Q24534958 |
Nestin as a marker of cancer stem cells | Q26851514 | ||
Systems biology of cisplatin resistance: past, present and future | Q26863585 | ||
Reelin and Notch1 cooperate in the development of the dentate gyrus | Q28250584 | ||
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma | Q29615604 | ||
Update on meningiomas | Q30461960 | ||
Maternal dietary choline deficiency alters angiogenesis in fetal mouse hippocampus | Q30495988 | ||
Adult medulloblastoma: multiagent chemotherapy with cisplatinum and etoposide: a single institutional experience. | Q33396889 | ||
Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors | Q33407691 | ||
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO | Q34324259 | ||
DNA methylation in the malignant transformation of meningiomas | Q34562612 | ||
Isolation and characterization of a population of stem-like progenitor cells from an atypical meningioma. | Q34625269 | ||
Suppression of cytochrome p450 reductase enhances long-term hematopoietic stem cell repopulation efficiency in mice | Q34904803 | ||
Molecular biological determinations of meningioma progression and recurrence | Q35145251 | ||
Genomic landscape of meningiomas. | Q35197844 | ||
Completeness and concordancy of WHO grade assignment for brain and central nervous system tumors in the United States, 2004-2011 | Q35638725 | ||
Chemotherapy for malignant gliomas based on histoculture drug response assay : a pilot study | Q35675900 | ||
Alternative splicing of CHEK2 and codeletion with NF2 promote chromosomal instability in meningioma | Q35763880 | ||
Anterior gradient protein 2 expression in high grade head and neck squamous cell carcinoma correlated with cancer stem cell and epithelial mesenchymal transition | Q35832228 | ||
Microarray Expression Data Identify DCC as a Candidate Gene for Early Meningioma Progression | Q35994740 | ||
CD133-positive cells might be responsible for efficient proliferation of human meningioma cells | Q36057307 | ||
RNAi-mediated abrogation of cathepsin B and MMP-9 gene expression in a malignant meningioma cell line leads to decreased tumor growth, invasion and angiogenesis. | Q36074431 | ||
Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors. | Q36116146 | ||
Cancer stem cells and cell size: A causal link? | Q36296444 | ||
Mechanisms and insights into drug resistance in cancer | Q36682301 | ||
Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma | Q36785144 | ||
Nestin in central nervous system cells | Q37057915 | ||
Nestin expression in human tumors and tumor cell lines. | Q37739407 | ||
Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development. | Q38040355 | ||
Merlin, the NF2 gene product | Q38105985 | ||
CXC receptor and chemokine expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferation | Q38303390 | ||
Epidemiological trends of histopathologically WHO classified CNS tumors in developing countries: systematic review | Q38339814 | ||
Cancer stem cells: a challenging paradigm for designing targeted drug therapies | Q38542817 | ||
Malignant progression to anaplastic meningioma: Neuropathology, molecular pathology, and experimental models | Q38572601 | ||
Glioma tissue obtained by modern ultrasonic aspiration with a simple sterile suction trap for primary cell culture and pathological evaluation | Q38971990 | ||
Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinoma | Q38998339 | ||
Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells | Q39113924 | ||
Comparative morphological and immunohistochemical study of human meningioma after intracranial transplantation into nude mice | Q39419510 | ||
The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection | Q39470412 | ||
Cellular responses to etoposide: cell death despite cell cycle arrest and repair of DNA damage | Q39757799 | ||
A comparison of the cell lines used in meningioma research | Q40015055 | ||
A genetic strategy to overcome the senescence of primary meningioma cell cultures | Q40300855 | ||
In vitro culture of various typed meningiomas and characterization of a human malignant meningioma cell line (HKBMM). | Q40395029 | ||
Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusion | Q42160720 | ||
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations | Q42548316 | ||
Decoding information in cell shape | Q42773442 | ||
A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma | Q43164381 | ||
The expression of tissue factor correlates with proliferative ability in meningioma | Q44527685 | ||
Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas | Q45167839 | ||
Isolation of mesenchymal stem-like cells in meningioma specimens. | Q45849463 | ||
Local chemotherapy with cisplatin-depot for glioblastoma multiforme. | Q46457345 | ||
Cancer stem cell definitions and terminology: the devil is in the details. | Q53140630 | ||
CNS cancer: molecular classification of glioma. | Q55053318 | ||
Chromosomal Constitution of Meningiomas | Q59057865 | ||
Phenotypic change of human cultured meningioma cells | Q73331753 | ||
Identification of CD105 (endoglin)-positive stem-like cells in rhabdoid meningioma | Q84895258 | ||
Spectroscopic detection of etoposide binding to chromatin components: the role of histone proteins | Q88132081 | ||
P921 | main subject | neoplastic stem cells | Q1638475 |
P304 | page(s) | 72 | |
P577 | publication date | 2017-07-21 | |
P1433 | published in | Cancer Cell International | Q1829859 |
P1476 | title | Pleomorphism and drug resistant cancer stem cells are characteristic of aggressive primary meningioma cell lines | |
P478 | volume | 17 |
Q64945719 | Array expression meta-analysis of cancer stem cell genes identifies upregulation of PODXL especially in DCC low expression meningiomas. |
Q90800024 | Association Between CD133, CD44, and Nestin Expression and Prognostic Factors in High-Grade Meningioma |
Q54983777 | In situ characterization of stem cells-like biomarkers in meningiomas. |
Q93080668 | Leveraging the Role of the Metastatic Associated Protein Anterior Gradient Homologue 2 in Unfolded Protein Degradation: A Novel Therapeutic Biomarker for Cancer |
Q91386928 | Malignant Transformation and Spine Metastasis of an Intracranial Grade I Meningioma: In Situ Immunofluorescence Analysis of Cancer Stem Cells Case Report and Literature Review |
Search more.